| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.76.2.442 |
| P698 | PubMed publication ID | 3608127 |
| P2093 | author name string | M Talajic | |
| S Nattel | |||
| M Quantz | |||
| M DeRoode | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amiodarone | Q410061 |
| P304 | page(s) | 442-449 | |
| P577 | publication date | 1987-08-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: evidence for calcium channel-blocking activity | |
| P478 | volume | 76 |
| Q46596705 | Acute effects of amiodarone on membrane properties, refractoriness, and conduction in guinea pig papillary muscles |
| Q36660391 | Amiodarone in Long Term Prophylaxis |
| Q33613145 | Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial |
| Q35313411 | Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias |
| Q33777249 | Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent |
| Q28376427 | Antiadrenergic effect of chronic amiodarone therapy in human heart failure |
| Q51381485 | Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits. |
| Q40388359 | Antiarrhythmic drug classifications and the clinician: a gambit in the land of chaos |
| Q36663794 | Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance |
| Q30469749 | Antiarrhythmic drug therapy in the treatment of atrial fibrillation. |
| Q43825463 | Class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) on action potentials and membrane currents in rabbit sino-atrial node preparations |
| Q37120884 | Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia |
| Q46651841 | Comparison of acute electrophysiological effects of amiodarone and its metabolite desethylamiodarone in Langendorff perfused guinea pig hearts. |
| Q35873960 | Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes |
| Q44380831 | Concentration dependent mitochondrial effect of amiodarone |
| Q40490665 | Drug effects on the electrocardiogram. A review of their clinical importance |
| Q44459901 | Effect of amiodarone on dispersion of atrial refractoriness and cycle length in patients with atrial fibrillation |
| Q92669207 | In silico study of the effects of anti-arrhythmic drug treatment on sinoatrial node function for patients with atrial fibrillation |
| Q41630478 | Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management |
| Q46681872 | Quantification of rate-dependent effects of verapamil, diltiazem, and digoxin on atrioventricular conduction |
| Q38193981 | Recent advances in understanding the pharmacology of amiodarone. |
| Q53969883 | Sematilide blocks the inward rectifier potassium channel in isolated guinea pig ventricular myocytes. |
| Q44240017 | Storms of ventricular tachyarrhythmias associated with primary hyperparathyroidism in a patient with dilated cardiomyopathy |
| Q40395459 | The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations. |
| Q36650575 | The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis |
| Q30471976 | Treatment strategies for atrial fibrillation |
| Q42556244 | Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation |
Search more.